Chemoembolization of hepatocellular carcinomas a study of the biodistribution and pharmacokinetics of doxorubicin
暂无分享,去创建一个
D. Heresbach | J. Raoul | P. Bourguet | R. Duvauferrier | J. Bretagne | D. Ferrer | M. Messner | M. Gosselin
[1] M. Lishner,et al. Reduced cardiotoxicity of doxorubicin by a 6‐hour infusion regimen. A prospective randomized evaluation , 1990, Cancer.
[2] S. Fukushima,et al. Hepatic arterial injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma , 1989, Cancer.
[3] M. Tatsuta,et al. Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil. , 1989, Gastroenterology.
[4] D. Heresbach,et al. [Chemotherapy combined with Lipiodol. In vitro study of the kinetics of release of adriamycin]. , 1989, Gastroenterologie clinique et biologique.
[5] K. Hasuo,et al. A 5‐year experience of lipiodolization: Selective regional chemotherapy for 200 patients with hepatocellular carcinoma , 1989, Hepatology.
[6] B. V. Van Beers,et al. Transcatheter Arterial Chemotherapy Using Doxorubicin, Iodized Oil and Gelfoam Embolization in Hepatocellular Carcinoma , 1989, Acta radiologica.
[7] E. Sigurdson,et al. Regional hepatic arterial infusion of degradable starch microspheres increases fluorodeoxyuridine (FUdR) tumor uptake. , 1989, Surgery.
[8] S Sawada,et al. Transcatheter oily chemoembolization of hepatocellular carcinoma. , 1989, Radiology.
[9] Y. Deugnier,et al. Hepatic artery injection of I-131-labeled lipiodol. Part II. Preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastases. , 1988, Radiology.
[10] S. Fukushima,et al. Selective accumulation of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine (FdUrd-C8) and sustained release of its active metabolites in VX-2 rabbit hepatoma following intraarterial administration of FdUrd-C8 solution in Lipiodol. , 1988, Cancer research.
[11] J. Raoul,et al. Hepatic artery injection of I-131-labeled lipiodol. Part I. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases. , 1988, Radiology.
[12] M. Makuuchi,et al. Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. , 1987, Radiology.
[13] L L Fajardo,et al. Excretory urography using computed radiography. , 1987, Radiology.
[14] Y. Deugnier,et al. [Lipiodolized angiography in hepatocellular carcinomas. Contribution of iodine-131-labelled lipiodol]. , 1986, Journal de radiologie.
[15] J. Ridge,et al. Intra-arterial infusion of doxorubicin with degradable starch microspheres. Improvement of hepatic tumor drug uptake. , 1986, Archives of surgery.
[16] H Inoue,et al. Treatment of Hepatocellular Carcinoma by Transarterial Injection of Anticancer Agents in Iodized Oil Suspension or of Radioactive Iodized Oil Solution , 1986, Acta radiologica: diagnosis.
[17] S. Maki,et al. Image enhancement in computerized tomography for sensitive diagnosis of liver cancer and semiquantitation of tumor selective drug targeting with oily contrast medium , 1985, Cancer.
[18] S. Tashiro,et al. Selective targeting of anti‐cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium , 1984, Cancer.
[19] H. Maeda,et al. Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image. , 1984, Cancer research.
[20] K. Hasuo,et al. Selective effects of lipiodolized antitumor agents , 1984, Journal of surgical oncology.
[21] S. Tashiro,et al. Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report. , 1983, European journal of cancer & clinical oncology.
[22] H. Ohishi,et al. Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents. , 1985, Radiology.
[23] P. Wilkinson,et al. Liquid Chromatographic Analysis of Adriamycin and Metabolites in Biological Fluids , 1978 .